Blaustein Robert bought EWTX
January 21, 2025 · Form 4 insider transaction
Blaustein Robert bought 160,000 shares of Edgewise Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
160,000
Price
$0.00
Total value
N/A
InsiderBlaustein Robert
RoleOfficer
SecurityStock Options (Right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 21, 2025
Filing dateJanuary 23, 2025
Shares owned after160,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
1/4th of the shares subject to the option become vested and exercisable on January 21, 2026 and 1/48th of the shares subject to the option continue to vest each month thereafter, subject to the Reporting Person continuing as a service provider through each vest date.